Clinical Roundup Study finds TNBC tumors with an increase in immune cells have lower risk of recurrence after surgery April 05, 2024Vol.50 No.14
Clinical Roundup Novel treatment for T-cell leukemias and lymphomas demonstrates promise in preclinical study April 05, 2024Vol.50 No.14
Clinical Roundup UTSW discovers protective ‘acid wall’ formed by cancer cells April 05, 2024Vol.50 No.14
Drugs & Targets Ipsen and Sutro Biopharma form global licensing deal for an ADC targeting solid tumors April 05, 2024Vol.50 No.14
Drugs & Targets Scripius and Avera collaborate to reduce prescription costs April 05, 2024Vol.50 No.14
Conversation with The Cancer Letter Rathmell: A tough budget is an opportunity to make sure NCI is “doing what is best for the American public” March 29, 2024Vol.50 No.13By Paul Goldberg
Capitol Hill With reduced FY24 funding, NCI prepares to make cuts March 29, 2024Vol.50 No.13By Matthew Bin Han Ong
Regulatory News Exercising new powers, FDA issues Complete Response Letters based on insufficient enrollment in confirmatory trials March 29, 2024Vol.50 No.13By Paul Goldberg
